Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Central Airway Stenosis
NCT: NCT07191860 · RECRUITING
Brief Summary
The OXYGEN-RCT trial is a randomized, controlled, double blinded, prospective, multi-center trial to demonstrate the safety and efficacy in adult benign central airway stenosis. Participates will be in a 1:1 allocation to treatment with the Airiver Pulmonary DCB or standard of care laryngoscopic/bronchoscopic balloon dilation, respectively.
Frequently Asked Questions
What is Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Central Airway Stenosis?
Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Central Airway Stenosis is a clinical trial registered under NCT07191860. Current status: RECRUITING.
What is the status of NCT07191860?
The current status of NCT07191860 (Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Central Airway Stenosis) is: RECRUITING.
When did Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Central Airway Stenosis start?
Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Central Airway Stenosis started on 2026-02-24.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.